Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose ; volume:16 ; number:1 ; day:26 ; month:4 ; year:2018 ; pages:1-11 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (26.4.2018), 1-11, 12.2018
- Urheber
-
O’Leary, Michael P.
- Beteiligte Personen und Organisationen
-
Choi, Audrey H.
Kim, Sang-In
Chaurasiya, Shyambabu
Lu, Jianming
Park, Anthony K.
Woo, Yanghee
Warner, Susanne G.
Fong, Yuman
Chen, Nanhai G.
SpringerLink (Online service)
- DOI
-
10.1186/s12967-018-1483-x
- URN
-
urn:nbn:de:101:1-2018063019021133359542
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- O’Leary, Michael P.
- Choi, Audrey H.
- Kim, Sang-In
- Chaurasiya, Shyambabu
- Lu, Jianming
- Park, Anthony K.
- Woo, Yanghee
- Warner, Susanne G.
- Fong, Yuman
- Chen, Nanhai G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines
Exhibits
Exhibits
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines
Exhibits
Exhibits
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms
Oncolytic therapy with vaccinia virus GLV-1h68 : comparative microarray analysis of infected xenografts and human tumor cell lines
Exhibits
Exhibits
A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68